Report overview
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
This report aims to provide a comprehensive presentation of the global market for Travelers Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Travelers Vaccines. This report contains market size and forecasts of Travelers Vaccines in global, including the following market information:
Global Travelers Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Travelers Vaccines Market Sales, 2018-2023, 2024-2029, (K Doses)
Global top five Travelers Vaccines companies in 2022 (%)
The global Travelers Vaccines market was valued at US$ 3460.7 million in 2022 and is projected to reach US$ 6095 million by 2029, at a CAGR of 8.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
We surveyed the Travelers Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Travelers Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Travelers Vaccines Market Segment Percentages, by Type, 2022 (%)
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Global Travelers Vaccines Market, by End Users, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Travelers Vaccines Market Segment Percentages, by End Users, 2022 (%)
Tourists
Students
Workers
Others
Global Travelers Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Travelers Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Travelers Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Travelers Vaccines revenues share in global market, 2022 (%)
Key companies Travelers Vaccines sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Travelers Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Outline of Major Chapters:
Chapter 1: Introduces the definition of Travelers Vaccines, market overview.
Chapter 2: Global Travelers Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by end users, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Travelers Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Travelers Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
